Henri Lichenstein is the founder of Drug Farm. Drug Farm has raised $138M in total funding. Latest round: Series D. Based in Albany, New York, USA.
Henri Lichenstein, Ph.D., is the Co-founder and Chief Executive Officer of Drug Farm, a biotechnology company developing first-in-class drugs for hepatitis B, cancer, and autoimmune diseases. He previously served as a longtime vice chair of genetics at Yale University.
Full founder directory · Investor directory · Company funding database · Fundraising library